Impact of mepolizumab in severe asthma with nasal polyps Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021
Differential treatment response to mepolizumab in severe eosinophilic asthma with nasal polyps Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020
Dupilumab reduces blood and nasal biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps with and without comorbid asthma: SINUS-52 trial Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020
Mepolizumab reduces nasal symptoms in asthmatic patients with chronic rhino-sinusitis and nasal polyposis: a 12 months real-life study Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020
Aspirin-induced urticaria/angioedema without respiratory symptoms in severe asthmatics with nasal polyposis Source: Eur Respir J 2002; 20: Suppl. 38, 512s Year: 2002
Impact of biologic therapy in severe asthma with nasal polyps Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
Type 2 inflammation-related comorbidities among patients with asthma, chronic rhinosinusitis with nasal polyps, and atopic dermatitis Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020
Effect of anti-IL5 treatment on symptoms of chronic rhinosinusitis, otitis and hearing loss in patients with severe eosinophilic asthma Source: International Congress 2019 – Clinical approach to asthma management Year: 2019
The impact of targeted therapy in children with uncontrolled allergic persistent severe asthma and nasal polyps Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities Year: 2017
Patient characteristics and treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) in Canada Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
Perception of nocturnal nasal obstruction in chronic rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 565s Year: 2005
Effects of therapy for rhinosinusitis in signs and symptoms of asthma in children Source: Eur Respir J 2007; 30: Suppl. 51, 383s Year: 2007
Pathophysiology of airway hyperresponsiveness in patients with nasal polyposis Source: Annual Congress 2011 - Phenotyping airway diseases Year: 2011
Chronic paranasal sinusitis exacerbates allergic inflammation in patients with asthma and contributes to refractoriness to treatment Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012
Nasal mucosa biopsy in patients with severe bronchial asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Quality of life, clinical symptoms and nasal obstruction in patients with allergic rhinitis Source: Eur Respir J 2003; 22: Suppl. 45, 418s Year: 2003
IL-19 as putative biomarker for chronic rhinosinusitis with nasal polyps Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010
Dupilumab improves all ACQ-5 individual items in patients with chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma: results from a phase 2a trial Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017
Bronchodilator efficacy and bronchial responsiveness in patients with bronchodilator-responsive chronic cough Source: Annual Congress 2006 - Established and experimental therapies for allergic asthma Year: 2006
Bronchodilator efficacy and bronchial responsiveness in patients with bronchodilator-responsive chronic cough Source: Annual Congress 2009 - Accuracy in lung function testing Year: 2009